<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02800837</url>
  </required_header>
  <id_info>
    <org_study_id>ST2016-01</org_study_id>
    <nct_id>NCT02800837</nct_id>
  </id_info>
  <brief_title>Clinical Study to Evaluate the STENTYS Xposition S for Treatment of Unprotected Left Main Coronary Artery Disease</brief_title>
  <acronym>TRUNC</acronym>
  <official_title>Multicenter Prospective Clinical Study of the STENTYS Xposition S for Treatment of Unprotected Left Main Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stentys</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stentys</source>
  <brief_summary>
    <textblock>
      Prospective, non-randomized, multi-center study assessing the long term safety and efficacy
      of the self expandable sirolimus eluting Xposition S stent in the treatment of unprotected
      left main coronary artery disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the treatment of unprotected left main coronary artery (ULMCA) disease, previous
      mono-center studies have shown promising results with the previous generation of the
      self-expandable STENTYS stent (paclitaxel eluting stent, delivered via withdrawal of a
      sheath).

      The TRUNC study aims at assessing at large scale the Xposition S in the treatment of ULMCA
      disease. The Xposition S is a sirolimus eluting stent, mounted on a balloon delivery system.
      The study aims at collecting clinical practice routine data from 200 patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Endpoint- Target Lesion Failure (TLF)</measure>
    <time_frame>12 months post-procedure</time_frame>
    <description>TLF defined as cardiac death, MI not attributable to a non target vessel, or clinically driven target lesion revascularization</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy Endpoint - Angiographic Success</measure>
    <time_frame>12 months post-procedure</time_frame>
    <description>Achievement of &lt;20% final residual stenosis at target lesion (visual estimation) with TIMI 3 flow in main branch</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>48 hours post procedure (hospital discharge)</time_frame>
    <description>Angiographic success without occurence of death, target lesion related MI or target lesion revascularization prior to hospital discharge visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TLF</measure>
    <time_frame>30 days post procedure</time_frame>
    <description>TLF defined as cardiac death, Myocardial Infarction(MI) not attributable to a non target vessel, or clinically driven target lesion revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Death Rate</measure>
    <time_frame>30 days, 12 months and 24 months post procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MI rate (not attributable to a non target vessel)</measure>
    <time_frame>30 days, 12 months and 24 months post procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinically Driven Target Lesion Revascularization</measure>
    <time_frame>30 days, 12 months and 24 months post procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke Events Rate</measure>
    <time_frame>30 days, 12 and 24 months post procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent Thrombosis Events Rate</measure>
    <time_frame>30-day, 12-month and 2 year post-procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Index Procedure Duration</measure>
    <time_frame>End of the index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluoroscopy Time, during Index Procedure</measure>
    <time_frame>End of the index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute Stent Malappositon by IVUS (IVUS Substudy)</measure>
    <time_frame>End of the index procedure</time_frame>
    <description>Assessed in a subset of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimal Lumen Area by IVUS (IVUS substudy)</measure>
    <time_frame>End of the index procedure</time_frame>
    <description>Assessed in a subset of patients</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Coronary Artery Disease (Left Main)</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with coronary artery stenosis (unprotected left main coronary artery), indicated
        for Percutaneous Coronary Intervention (PCI) and Xposition S stent treatment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Main Inclusion Criteria:

          -  Subject ≥ 18 years old;

          -  Presence of coronary artery stenosis in the unprotected Left Main (LM) Coronary Artery
             which is indicated for PCI and Xposition S stent treatment

          -  Left Main Coronary Artery reference vessel diameter ranging from 2.5 mm to 6.0 mm;

          -  The subject is able to provide voluntary informed consent, willing to comply with all
             study requirements and sign the written informed consent.

        Main Exclusion Criteria:

          -  Recent STEMI (&lt;1 month) ;

          -  SYNTAX score ≥ 33 ;

          -  Highly calcified lesions or excessive tortuosity at target lesion site;

          -  Subject unable to comply with dual antiplatelet therapy as recommended per guidelines;

          -  Planned cardiac surgery or valve intervention within the next 12 months.

          -  Participation to other investigational drug or device studies that have not reached
             their primary endpoint.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ferraroto Hospital - Catania University</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Corrado Tamburino</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinica Mediterranea</name>
      <address>
        <city>Naples</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Carlo Briguori</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Gallen Kantonsspital</name>
      <address>
        <city>St Gallen</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Weilenmann</last_name>
      <phone>+41 71 494 10 51</phone>
    </contact>
    <investigator>
      <last_name>Daniel Weillenmann</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bristol Heart Institute</name>
      <address>
        <city>Bristol</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Andreas Baumbach</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Briguori C, Visconti G, Donahue M, Focaccio A, Mitomo S, Kawamoto H, Nakamura S. The STENTYS® paclitaxel-eluting stent in the treatment of unprotected distal left main. Catheter Cardiovasc Interv. 2015 Sep;86(3):E131-9. doi: 10.1002/ccd.25874. Epub 2015 Feb 25.</citation>
    <PMID>25639945</PMID>
  </reference>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2016</study_first_submitted>
  <study_first_submitted_qc>June 10, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 15, 2016</study_first_posted>
  <last_update_submitted>June 10, 2016</last_update_submitted>
  <last_update_submitted_qc>June 10, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>left main</keyword>
  <keyword>stent</keyword>
  <keyword>self-expandable</keyword>
  <keyword>DES</keyword>
  <keyword>Stentys</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

